| |
| |
|
| Insider
Information: |
Otto Dawn Parsell |
| Relationship: |
EVP, Clinical Developm... |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
3,465 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
3,465 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Tricida, Inc. |
TCDA |
EVP, Clinical Developm... |
2021-12-31 |
3,465 |
2019-01-07 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
36 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TCDA |
Tricida, Inc. |
Sr VP, Clinical Development |
• – – |
2019-01-07 |
4 |
AS |
$23.27 |
$15,475 |
D/D |
(665) |
0 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Sr VP, Clinical Development |
• – – |
2019-03-13 |
4 |
AS |
$25.00 |
$50,000 |
D/D |
(2,000) |
0 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Sr VP, Clinical Development |
• – – |
2019-03-13 |
4 |
OE |
$0.80 |
$1,600 |
D/D |
2,000 |
2,000 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Sr VP, Clinical Development |
• – – |
2019-03-15 |
4 |
AS |
$25.02 |
$19,290 |
D/D |
(771) |
0 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Sr VP, Clinical Development |
• – – |
2019-03-15 |
4 |
OE |
$0.80 |
$617 |
D/D |
771 |
771 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Sr VP, Clinical Development |
• – – |
2019-03-18 |
4 |
OE |
$0.80 |
$1,383 |
D/D |
1,729 |
1,729 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Sr VP, Clinical Development |
• – – |
2019-03-18 |
4 |
AS |
$25.02 |
$43,260 |
D/D |
(1,729) |
0 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Sr VP, Clinical Development |
• – – |
2019-03-28 |
4 |
OE |
$0.80 |
$12,400 |
D/D |
15,500 |
15,500 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Sr VP, Clinical Development |
• – – |
2019-03-28 |
4 |
AS |
$30.74 |
$476,470 |
D/D |
(15,500) |
0 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Sr VP, Clinical Development |
• – – |
2019-07-03 |
4 |
OE |
$0.80 |
$22,763 |
D/D |
15,000 |
15,000 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Sr VP, Clinical Development |
• – – |
2019-07-03 |
4 |
AS |
$37.04 |
$570,675 |
D/D |
(15,407) |
0 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Sr VP, Clinical Development |
• – – |
2019-07-29 |
4 |
OE |
$1.68 |
$8,400 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Sr VP, Clinical Development |
• – – |
2019-07-29 |
4 |
AS |
$31.19 |
$155,950 |
D/D |
(5,000) |
0 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Sr VP, Clinical Development |
• – – |
2019-08-28 |
4 |
AS |
$33.67 |
$168,455 |
D/D |
(5,000) |
0 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Sr VP, Clinical Development |
• – – |
2019-08-28 |
4 |
OE |
$1.68 |
$8,400 |
D/D |
5,000 |
3,500 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Sr VP, Clinical Development |
• – – |
2019-09-25 |
4 |
OE |
$1.68 |
$8,904 |
D/D |
5,300 |
5,300 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Sr VP, Clinical Development |
• – – |
2019-09-25 |
4 |
AS |
$32.40 |
$172,257 |
D/D |
(5,300) |
0 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Sr VP, Clinical Development |
• – – |
2019-10-28 |
4 |
OE |
$1.68 |
$12,294 |
D/D |
5,300 |
4,774 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Sr VP, Clinical Development |
• – – |
2019-10-28 |
4 |
AS |
$37.11 |
$197,438 |
D/D |
(5,300) |
0 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Sr VP, Clinical Development |
• – – |
2020-01-02 |
4/A |
OE |
$1.68 |
$7,140 |
D/D |
4,250 |
4,505 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Sr VP, Clinical Development |
• – – |
2020-01-02 |
4 |
AS |
$36.84 |
$157,421 |
D/D |
(4,250) |
255 |
0 |
% |
|
| TCDA |
Tricida, Inc. |
Sr VP, Clinical Development |
• – – |
2020-01-02 |
4 |
OE |
$1.68 |
$7,140 |
D/D |
4,250 |
2,620 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Sr VP, Clinical Development |
• – – |
2020-02-03 |
4 |
OE |
$1.68 |
$10,550 |
D/D |
4,250 |
778 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Sr VP, Clinical Development |
• – – |
2020-02-03 |
4 |
AS |
$35.58 |
$156,668 |
D/D |
(4,250) |
255 |
0 |
% |
|
| TCDA |
Tricida, Inc. |
EVP, Clinical Development |
• – – |
2020-03-02 |
4 |
OE |
$1.68 |
$10,550 |
D/D |
4,250 |
778 |
0 |
- |
|
36 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
